BCG Vaccine News and Research

RSS
The BCG Vaccine is a vaccine containing bacillus Calmette-Guerin (BCG), an attenuated strain of Mycobacterium bovis, with non-specific immunoadjuvant and immunotherapeutic activities. Although the mechanism of its anti-tumor activity is unclear, immunization with BCG vaccine likely activates a Th1 cytokine response that includes the induction of interferon. Vaccination with BCG vaccine may be immunoprotective against infection with Mycobacterium tuberculosis.
Experimental vaccine strategy shows great promise in treating tuberculosis

Experimental vaccine strategy shows great promise in treating tuberculosis

Clinical testing begins for temperature-stable experimental tuberculosis vaccine

Clinical testing begins for temperature-stable experimental tuberculosis vaccine

New TB vaccine effective in half of the population in phase II trials

New TB vaccine effective in half of the population in phase II trials

Aeras announces publication of Phase 2 results of two TB vaccines

Aeras announces publication of Phase 2 results of two TB vaccines

Advanced genetics study of TB bacteria uncovers virulent 'Beijing lineage' strain among young adults

Advanced genetics study of TB bacteria uncovers virulent 'Beijing lineage' strain among young adults

Researchers discover new weapon to combat tuberculosis

Researchers discover new weapon to combat tuberculosis

Study finds no association between BCG vaccine and childhood asthma

Study finds no association between BCG vaccine and childhood asthma

BCG vaccine protects against infection in adulthood when most transmission occurs, study shows

BCG vaccine protects against infection in adulthood when most transmission occurs, study shows

Clinical study shows new mechanism that BCG vaccine uses to reverse advanced type 1 diabetes

Clinical study shows new mechanism that BCG vaccine uses to reverse advanced type 1 diabetes

One-shot vaccine passes key preclinical test in newborn monkey models

One-shot vaccine passes key preclinical test in newborn monkey models

Insights into immune system pathways may be key to developing effective TB vaccine

Insights into immune system pathways may be key to developing effective TB vaccine

Antibody protection may help control infection caused by TB bacteria

Antibody protection may help control infection caused by TB bacteria

New skin test for TB infection proves safe, effective in clinical trials

New skin test for TB infection proves safe, effective in clinical trials

New biomarker discovery could improve chances of developing effective TB vaccine

New biomarker discovery could improve chances of developing effective TB vaccine

Analyzing potential TB vaccine

Analyzing potential TB vaccine

GHIT Fund invests $10.7 million to fight malaria, TB, leishmaniasis and dengue

GHIT Fund invests $10.7 million to fight malaria, TB, leishmaniasis and dengue

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Radboud university medical center reveals how BCG vaccine works against tuberculosis

Radboud university medical center reveals how BCG vaccine works against tuberculosis

New systematic review questions effectiveness of MVA85A vaccine on TB

New systematic review questions effectiveness of MVA85A vaccine on TB